• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶酶体亲和剂可逆转人类癌细胞中的多药耐药性。

Lysosomotropic agents reverse multiple drug resistance in human cancer cells.

作者信息

Shiraishi N, Akiyama S, Kobayashi M, Kuwano M

出版信息

Cancer Lett. 1986 Mar;30(3):251-9. doi: 10.1016/0304-3835(86)90049-2.

DOI:10.1016/0304-3835(86)90049-2
PMID:3697945
Abstract

Chloroquine, a well-known lysosomotropic amine, partially reversed the resistance of multi-drug-resistant KB carcinoma cells to adriamycin, daunomycin, vincristine, vinblastine and actinomycin D. Other lysosomotropic amines, propranolol, atropine, amantadine and nicotine, also restored the sensitivity of multi-drug-resistant cells to the anticancer drugs. The increased rate of accumulation of [3H] daunomycin by chloroquine was more prominent in the resistant KB-ChR-24 cells than in the parental KB cells. Chloroquine inhibited the efflux of daunomycin from the resistant cells. Circumvention of multiple drug resistance in human KB carcinoma cells by the agents is discussed in relation to lysosomal function.

摘要

氯喹是一种著名的亲溶酶体胺,它能部分逆转多药耐药的KB癌细胞对阿霉素、柔红霉素、长春新碱、长春花碱和放线菌素D的耐药性。其他亲溶酶体胺,如普萘洛尔、阿托品、金刚烷胺和尼古丁,也能恢复多药耐药细胞对抗癌药物的敏感性。氯喹使[3H]柔红霉素在耐药的KB-ChR-24细胞中的积累速率增加,这在耐药细胞中比在亲代KB细胞中更为显著。氯喹抑制了柔红霉素从耐药细胞中的外流。本文结合溶酶体功能讨论了这些药物对人KB癌细胞多药耐药性的规避作用。

相似文献

1
Lysosomotropic agents reverse multiple drug resistance in human cancer cells.溶酶体亲和剂可逆转人类癌细胞中的多药耐药性。
Cancer Lett. 1986 Mar;30(3):251-9. doi: 10.1016/0304-3835(86)90049-2.
2
Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.多药耐药和敏感KB细胞中柔红霉素摄取与外排的单细胞分析:维拉帕米及其他药物的作用
Cancer Res. 1986 Nov;46(11):5941-6.
3
Circumvention of multiple-drug resistance in human cancer cells by thioridazine, trifluoperazine, and chlorpromazine.
J Natl Cancer Inst. 1986 May;76(5):839-44.
4
Effect of bisbenzylisoquinoline (biscoclaurine) alkaloids on multidrug resistance in KB human cancer cells.双苄基异喹啉(双古伦宾)生物碱对KB人癌细胞多药耐药性的影响。
Cancer Res. 1987 May 1;47(9):2413-6.
5
Chloroquine enhancement of anticancer drug cytotoxicity in multiple drug resistant human leukemic cells.氯喹增强多药耐药人白血病细胞中抗癌药物的细胞毒性
Biochem Pharmacol. 1986 Dec 1;35(23):4303-10. doi: 10.1016/0006-2952(86)90710-0.
6
Reversal of multidrug resistance by synthetic isoprenoids in the KB human cancer cell line.
Cancer Res. 1986 Sep;46(9):4453-7.
7
Potentiation of some anticancer agents by dipyridamole against drug-sensitive and drug-resistant cancer cell lines.双嘧达莫对某些抗癌药物在敏感和耐药癌细胞系中的增效作用。
Jpn J Cancer Res. 1989 May;80(5):475-81. doi: 10.1111/j.1349-7006.1989.tb02339.x.
8
Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes.阿霉素筛选的U-937细胞中囊泡状蒽环类药物的蓄积:溶酶体的作用
Blood. 1997 May 15;89(10):3745-54.
9
Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells.液泡H⁺-ATP酶抑制剂会损害柔红霉素在溶酶体中的优先积累,并逆转耐药性肾上皮细胞对蒽环类药物的耐药性。
Biochem J. 2003 Feb 15;370(Pt 1):185-93. doi: 10.1042/BJ20021411.
10
Drug transport mechanisms in HL60 cells isolated for resistance to adriamycin: evidence for nuclear drug accumulation and redistribution in resistant cells.对阿霉素耐药的HL60细胞中的药物转运机制:耐药细胞中核药物积累和重新分布的证据。
Cancer Res. 1992 Jun 1;52(11):3157-63.

引用本文的文献

1
St-N, a novel alkaline derivative of stevioside, reverses docetaxel resistance by targeting lysosomes in vitro and in vivo.甜菊苷新型碱性衍生物St-N通过在体外和体内靶向溶酶体逆转多西他赛耐药性。
PLoS One. 2024 Dec 27;19(12):e0316268. doi: 10.1371/journal.pone.0316268. eCollection 2024.
2
Ursolic Acid Impairs Cellular Lipid Homeostasis and Lysosomal Membrane Integrity in Breast Carcinoma Cells.熊果酸破坏乳腺癌细胞的细胞脂质稳态和溶酶体膜完整性。
Cells. 2022 Dec 16;11(24):4079. doi: 10.3390/cells11244079.
3
Influence of lysosomal sequestration on multidrug resistance in cancer cells.
溶酶体隔离对癌细胞多药耐药性的影响。
Cancer Drug Resist. 2019 Mar 19;2(1):31-42. doi: 10.20517/cdr.2018.23. eCollection 2019.
4
Enhanced lysosomal function is critical for paclitaxel resistance in cancer cells: reversed by artesunate.增强溶酶体功能对于癌细胞对紫杉醇的耐药性至关重要:青蒿琥酯可逆转这一现象。
Acta Pharmacol Sin. 2021 Apr;42(4):624-632. doi: 10.1038/s41401-020-0445-z. Epub 2020 Jul 23.
5
Synergy between Photodynamic Therapy and Dactinomycin Chemotherapy in 2D and 3D Ovarian Cancer Cell Cultures.二维和三维卵巢癌细胞培养中光动力疗法与放线菌素化疗的协同作用。
Int J Mol Sci. 2020 Apr 30;21(9):3203. doi: 10.3390/ijms21093203.
6
Lysosomal Fusion: An Efficient Mechanism Increasing Their Sequestration Capacity for Weak Base Drugs without Apparent Lysosomal Biogenesis.溶酶体融合:一种增加弱堿性药物蓄积能力的有效机制,而不会明显引起溶酶体生物发生。
Biomolecules. 2020 Jan 3;10(1):77. doi: 10.3390/biom10010077.
7
The Lysosomal Sequestration of Tyrosine Kinase Inhibitors and Drug Resistance.溶酶体对酪氨酸激酶抑制剂的隔离与药物耐药性。
Biomolecules. 2019 Oct 31;9(11):675. doi: 10.3390/biom9110675.
8
Lysosomal P-gp-MDR1 Confers Drug Resistance of Brentuximab Vedotin and Its Cytotoxic Payload Monomethyl Auristatin E in Tumor Cells.溶酶体P-糖蛋白-MDR1赋予肿瘤细胞对本妥昔单抗及其细胞毒性载荷单甲基奥瑞他汀E的耐药性。
Front Pharmacol. 2019 Jul 17;10:749. doi: 10.3389/fphar.2019.00749. eCollection 2019.
9
Design, synthesis, and biological evaluation of 6-methoxy-2-arylquinolines as potential P-glycoprotein inhibitors.6-甲氧基-2-芳基喹啉作为潜在P-糖蛋白抑制剂的设计、合成及生物学评价
Iran J Basic Med Sci. 2018 Jan;21(1):9-18. doi: 10.22038/IJBMS.2017.21892.5616.
10
Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent.肿瘤学中药物的重新利用(ReDO)——普萘洛尔作为一种抗癌药物。
Ecancermedicalscience. 2016 Oct 12;10:680. doi: 10.3332/ecancer.2016.680. eCollection 2016.